Universite D’Angers;Centre National de la Recherche Scientifique (CNRS);Universite de Nantes;INSERM (Institut National de la Sante et de la Recherche Medicale)
The present invention relates to a melanoma antigen peptide comprising the amino acids sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4 and SEQ ID NO: 5 or a function-conservative variant thereof. Moreover the invention also relates to a melanoma antigen peptide according to the invention for use in the prevention or the treatment of melanoma in patient.